You will hear from industry experts on the current applications of imaging in all stages of drug design, in depth verity of imaging modalities and how they can be best applied in the development process, how to use imaging techniques to reduce the long term cost of drug development and case studies discussions on how to best standardize imaging result from multi centre clinical trials
Benefits of attending
Examine the benefits of different imaging modalities and she how they can be best applied in your investigations
Review case studies on the use of imaging in multi centre clinical trials and how different teams have overcome the challenges associated with them.
Determine how upcoming EU regulations will affect the way oncology trials use of imaging will be conducted
Gain knowledge of using imaging techniques, when used, can reduce the long term cost of drug development
Communicate with industry experts on the current applications of imaging in all stages of drug design
Participate at the interactive workshop on how molecular imaging can reduce the cost of drug development
Make sure not to miss this opportunity to attend and hear from our expert speakers, including:
• Werner Scheuer, Research Leader Preclinical Imaging, Roche Diagnostics
• Yanping Luo, Group Leader Translational Imaging, Abbott
• Peter Eggelton, Medical Director Oncology, Merck
• Paul McSheehy, Director Oncology, Novartis
• Anthony M Giamis, Head of Radiochemistry, Abbott
• Christopher Foley, Imaging Manager, GlaxoSmithKline
• Simon Walker-Samuel, Senior Research Associate, University College London
• Francois Lassailly, In-vivo Imaging Specialist, Cancer Research
TO BOOK
Please visit: http://www.smi-
Alternatively contact: Ninica Hussain 0207 827 6115 or nhussain@smi-
